Sign up for upcoming conferences in the PROGRAMS section! | Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions

Click Here To Save Now

Resources

Aug 15, 2024

Prevalence of AMD-related vision loss expected to increase as population ages

By Kate YoungFact checked by Heather Biele Key takeaways: Prevalence of AMD-related blindness decreased globally from 2000 to 2020. Older

Prevalence of AMD-related vision loss expected to increase as population ages

Aug 12, 2024

Sandoz announces FDA approval for new biosimilar

New Press Release The U.S. Food and Drug Administration (FDA) has approved Sandoz biosimilar Enzeevu™ (aflibercept-abzv) 2 mg vial kit

Sandoz announces FDA approval for new biosimilar

Aug 12, 2024

Multivitamins could potentially shorten your lifespan

By Lisa Marie Basile | Fact-checked by Davi Sherman | Published July 16, 2024 Key Takeaways A new cohort study published in JAMA Network Open analyzed data from nearly

Multivitamins could potentially shorten your lifespan

Aug 9, 2024

Ocular Therapeutix receives FDA nod for SOL-R registrational study of Axpaxli

New Study Ocular Therapeutix obtained FDA support to use the phase 3 SOL-R trial as the next step in the

Ocular Therapeutix receives FDA nod for SOL-R registrational study of Axpaxli

Aug 6, 2024

AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD

by: Steven Ferrucci, OD, FAAO Key takeaways: The AREDS2 supplement slowed the expansion of geographic atrophy toward the fovea by

AREDS2 supplement slows expansion of geographic atrophy, even in late-stage AMD

Jul 28, 2024

Stave off cognitive decline: Eat this mushroom

By Julia Ries | Fact-checked by Davi Sherman | Published July 25, 2024 Key Takeaways The lion’s mane mushroom is gaining popularity for its potential health benefits,

Stave off cognitive decline: Eat this mushroom

Jul 26, 2024

Heart Pounding, Stomach-Knotting: Stress & You

The Stress Response Your muscles tense, your heart races and your breath comes faster — we all know what stress

Heart Pounding, Stomach-Knotting: Stress & You

Jul 25, 2024

Could Metformin Fill the Bill for Geographic Atrophy Prevention?

Case-control study shows reduction in new-onset GA, particularly in nondiabetic patients by Charles Bankhead, Senior Editor, MedPage TodayJuly 22, 2024 STOCKHOLM —

Could Metformin Fill the Bill for Geographic Atrophy Prevention?

Jul 8, 2024

FDA approves Vabysmo prefilled syringe for retinal diseases

Key takeaways: The prefilled syringe is indicated for wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion. The

FDA approves Vabysmo prefilled syringe for retinal diseases

Jul 1, 2024

AI model helps predict anti-VEGF response in diabetic macular edema

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Joe Luvisi, MD, discusses the use of AI to predict

AI model helps predict anti-VEGF response in diabetic macular edema

Jun 25, 2024

Utilizing the immune system to combat dry eye disease

by: Walter O. Whitley OD, MBA, FAAO Exploring strategies for effective management of a multifaceted condition Dry eye disease (DED)

Utilizing the immune system to combat dry eye disease

Jun 25, 2024

Pegcetacoplan injection preserves visual function at 36 weeks in patients with geographic atrophy

By: David Hutton Positive data from the GALE long-term extension study showed patients developed fewer new scotomatous points with 36

Pegcetacoplan injection preserves visual function at 36 weeks in patients with geographic atrophy

Jun 11, 2024

FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin

Key takeaways: The Abbott Libre Rio was cleared for adults with type 2 diabetes who do not use insulin. The

FDA clears OTC CGMs for general public, adults with type 2 diabetes who do not use insulin

Jun 10, 2024

SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)

June 10, 2024 SYFOVRE is the only approved GA treatment to demonstrate a visual function benefit in a prespecified endpoint

SYFOVRE® (pegcetacoplan injection) Preserved Visual Function at 36 Months in GALE Extension Study in Geographic Atrophy (GA)

Jun 6, 2024

Avirmax Biopharma Inc receives IND approval from FDA

June 6, 2024 by: Martin David Harp The IND approval will allow the company to initiate a Phase I/IIa clinical

Avirmax Biopharma Inc receives IND approval from FDA

Jun 6, 2024

Stealth BioTherapeutics enrols first subject in dry AMD treatment trial

A new dry AMD study. The rate of change in the macular area of photoreceptor loss is the primary efficacy

Stealth BioTherapeutics enrols first subject in dry AMD treatment trial

May 30, 2024

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

      First-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patients

FDA Grants AI-Powered Notal Vision Home OCT “SCANLY” De Novo Marketing Authorization

May 30, 2024

Study: Low-dose aspirin doesn’t affect the incidence or progression of AMD

May 28, 2024, by; Lynda Charters Investigators undertook a secondary analysis of the effects of long-term, low-dose aspirin in over

Study: Low-dose aspirin doesn’t affect the incidence or progression of AMD

May 22, 2024

Press Release

Discover Hope Macular Degeneration Association Connects Patients with Vital Support Macular Degeneration Association offers free resources and events for all

Press Release

May 12, 2024

Happy Mother’s Day

                                       

Happy Mother’s Day

May 3, 2024

16 Ways to Modify Your Home if You Have Diabetic Macular Edema

Low vision can increase your risk of a fall or other mishap. Here’s a room-by-room guide to making your home

16 Ways to Modify Your Home if You Have Diabetic Macular Edema

May 3, 2024

Study finds link between body weight and retinal thickness

There appears to be a significant association between body weight, specifically preobesity and obesity, and changes in retinal thickness, according

Study finds link between body weight and retinal thickness

Apr 16, 2024

Treatment challenges in patients with nAMD

by: Lynda Charters David Eichenbaum, MD, discusses his experiences with aflibercept, faricimab. Reviewed by David Eichenbaum, MD David Eichenbaum, MD,

Treatment challenges in patients with nAMD

Apr 16, 2024

Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410

by: Sydney M Crago The Phase 1/2 study includes a dose-escalation phase of the study featuring 3 cohorts each one

Data and Safety Monitoring Board (DSMB) for Ocugen’s Phase 1/2 ArMaDa clinical approves medium dose of OCU410

Apr 15, 2024

New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain

By Lisa Marie Basile | Fact-checked by Davi Sherman -Published March 29, 2024 Key Takeaways New research has drawn a link between vitamin D deficiency (VDD)

New research links vitamin D deficiency and diabetic peripheral neuropathy—but questions still remain

Apr 10, 2024

The Complete Eye Health & Nutrition Guide: Eye Foods

New lower price- The Complete Eye Health & Nutrition Guide: Eye Foods New price $15.00 + $9.95 mailing costs- Limited

The Complete Eye Health & Nutrition Guide: Eye Foods

Apr 5, 2024

April is Women’s Eye Health and Safety Mont

Did you know that more women suffer from visual impairments than men, per the National Eye Institute? Two-thirds of blindness

April is Women’s Eye Health and Safety Mont

Apr 4, 2024

SpyGlass Pharma unveils 1-year data of drug delivery platform implanted during routine cataract surgery in patients diagnosed with glaucoma

by: David Hutton One year after implantation, the enduring IOP reduction remained consistent across all 3 dose strengths.

SpyGlass Pharma unveils 1-year data of drug delivery platform implanted during routine cataract surgery in patients diagnosed with glaucoma

Apr 3, 2024

ISS National Lab-sponsored study to test a novel gene therapy for AMD

by David Hutton An investigation is set to launch on SpaceX’s 30th Commercial Resupply Services mission to the International Space

ISS National Lab-sponsored study to test a novel gene therapy for AMD

Apr 2, 2024

Beyond the eclipse: The long-term effects of solar retinopathy

by: David Hutton Patients can experience solar retinopathy after viewing the eclipse without protection, but it also can occur from

Beyond the eclipse: The long-term effects of solar retinopathy

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.